Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.
You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.
Other companies in Checkpoint Therapeutics’s space includes: Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX) and Genfit (NASDAQ:GNFT).
Checkpoint Therapeutics has a consensus price target of $24.29.
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $3.19 last updated January 17, 2025 at 7:56 PM EST.
There are no upcoming dividends for Checkpoint Therapeutics.
Checkpoint Therapeutics’s Q4 earnings are confirmed for Friday, March 21, 2025.
There is no upcoming split for Checkpoint Therapeutics.
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.